{"version":"1.0","type":"link","title":"Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis.","author_name":"Alexander M 외","author_url":"https://prs-insight.online/author/Alexander%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89604","thumbnail_width":1200,"thumbnail_height":630}